ZentiSita 25 mg
ZentiSita 25 mg is a medicine authorised by Swissmedic under authorisation number 68990. The authorisation holder is Helvepharm AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 21 May 2024 and the authorisation is limited until 20 May 2029. ATC code A10BH01 places the medicine in the group Drugs used in diabetes.
| Authorisation number | 68990 |
|---|---|
| Name | ZentiSita 25 mg |
| Full name | ZentiSita 25 mg, Filmtabletten |
| Authorisation holder | Helvepharm AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | A10BH01 |
| First authorisation | 21 May 2024 |
| Authorisation validity | 20 May 2029 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | ZentiSita 25 mg, Filmtabletten | B | 21 May 2024 |
| 2 | ZentiSita 50 mg, Filmtabletten | B | 21 May 2024 |
| 3 | ZentiSita 100 mg, Filmtabletten | B | 21 May 2024 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 28 | Tablette(n) | A10BH01 | 07.06.2. | B |
| 2 | 98 | Tablette(n) | A10BH01 | 07.06.2. | B |
| 3 | 28 | Tablette(n) | A10BH01 | 07.06.2. | B |
| 4 | 98 | Tablette(n) | A10BH01 | 07.06.2. | B |
| 5 | 28 | Tablette(n) | A10BH01 | 07.06.2. | B |
| 6 | 98 | Tablette(n) | A10BH01 | 07.06.2. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is ZentiSita 25 mg authorised in Switzerland?
Yes. ZentiSita 25 mg is authorised by Swissmedic under authorisation number 68990, data as of 01 September 2026. The authorisation is limited until 20 May 2029.
Which dispensing category does ZentiSita 25 mg have?
ZentiSita 25 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of ZentiSita 25 mg?
The authorisation holder is Helvepharm AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.